Annual Short Term Debt
$210.66 M
+$193.22 M+1107.79%
December 31, 2024
Summary
- As of March 12, 2025, PCRX annual short term debt is $210.66 million, with the most recent change of +$193.22 million (+1107.79%) on December 31, 2024.
- During the last 3 years, PCRX annual short term debt has fallen by -$171.93 million (-44.94%).
- PCRX annual short term debt is now -44.94% below its all-time high of $382.59 million, reached on December 31, 2021.
Performance
PCRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$210.66 M
$6000.000.00%
December 31, 2024
Summary
- As of March 12, 2025, PCRX quarterly short term debt is $210.66 million, with the most recent change of +$6000.00 (0.00%) on December 31, 2024.
- Over the past year, PCRX quarterly short term debt has stayed the same.
- PCRX quarterly short term debt is now -44.94% below its all-time high of $382.59 million, reached on December 31, 2021.
Performance
PCRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PCRX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1107.8% | 0.0% |
| 3 y3 years | -44.9% | +4.4% |
| 5 y5 years | +4168.8% | +4.4% |
PCRX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.9% | +1107.8% | -44.9% | +2202.6% |
| 5 y | 5-year | -44.9% | +4168.8% | -44.9% | +5209.1% |
| alltime | all time | -44.9% | >+9999.0% | -44.9% | >+9999.0% |
Pacira BioSciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $210.66 M(+1107.8%) | $210.66 M(+0.0%) |
| Sep 2024 | - | $210.66 M(+2202.5%) |
| Jun 2024 | - | $9.15 M(-48.1%) |
| Mar 2024 | - | $17.64 M(+1.2%) |
| Dec 2023 | $17.44 M(-59.2%) | $17.44 M(+1.0%) |
| Sep 2023 | - | $17.27 M(-39.4%) |
| Jun 2023 | - | $28.48 M(+43.8%) |
| Mar 2023 | - | $19.80 M(-53.7%) |
| Dec 2022 | $42.77 M(-88.8%) | $42.77 M(+1.3%) |
| Sep 2022 | - | $42.24 M(+0.8%) |
| Jun 2022 | - | $41.91 M(-79.2%) |
| Mar 2022 | - | $201.70 M(-47.3%) |
| Dec 2021 | $382.59 M(+143.6%) | $382.59 M(+136.7%) |
| Sep 2021 | - | $161.63 M(+1.4%) |
| Jun 2021 | - | $159.32 M(+1.4%) |
| Mar 2021 | - | $157.15 M(+0.0%) |
| Dec 2020 | $157.07 M(+3082.8%) | $157.07 M(+2006.9%) |
| Sep 2020 | - | $7.46 M(-2.2%) |
| Jun 2020 | - | $7.62 M(+92.0%) |
| Mar 2020 | - | $3.97 M(-19.6%) |
| Dec 2019 | $4.93 M(+1360.1%) | $4.93 M(-2.1%) |
| Sep 2019 | - | $5.04 M(-18.3%) |
| Jun 2019 | - | $6.17 M(+10.5%) |
| Mar 2019 | - | $5.58 M(+1551.8%) |
| Dec 2018 | $338.00 K | $338.00 K(+1.2%) |
| Sep 2018 | - | $334.00 K(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $330.00 K(+0.9%) |
| Mar 2018 | - | $327.00 K(+0.9%) |
| Dec 2017 | $324.00 K(-99.7%) | $324.00 K(+1.3%) |
| Sep 2017 | - | $320.00 K(+0.3%) |
| Jun 2017 | - | $319.00 K(-58.0%) |
| Mar 2017 | - | $759.00 K(-99.3%) |
| Sep 2016 | - | $107.56 M(+1.1%) |
| Jun 2016 | - | $106.39 M(+1.1%) |
| Mar 2016 | - | $105.22 M(+1.1%) |
| Dec 2015 | $104.04 M(+0.9%) | $104.04 M(-0.8%) |
| Sep 2015 | - | $104.91 M(+1.0%) |
| Jun 2015 | - | $103.89 M(-0.2%) |
| Mar 2015 | - | $104.14 M(+1.0%) |
| Dec 2014 | $103.10 M(+4.2%) | $103.10 M(+1.0%) |
| Sep 2014 | - | $102.06 M(+1.0%) |
| Jun 2014 | - | $101.03 M(+1.0%) |
| Mar 2014 | - | $100.00 M(+1.0%) |
| Dec 2013 | $98.96 M(+1305.9%) | $98.96 M(+1.1%) |
| Sep 2013 | - | $97.93 M(>+9900.0%) |
| Sep 2012 | - | $837.00 K(-67.6%) |
| Mar 2012 | - | $2.58 M(-63.3%) |
| Dec 2011 | $7.04 M(+121.2%) | $7.04 M(+44.5%) |
| Sep 2011 | - | $4.87 M(-23.0%) |
| Jun 2011 | - | $6.33 M(+13.6%) |
| Mar 2011 | - | $5.57 M(+75.0%) |
| Dec 2010 | $3.18 M | $3.18 M(+93.4%) |
| Sep 2010 | - | $1.65 M |
FAQ
- What is Pacira BioSciences annual short term debt?
- What is the all time high annual short term debt for Pacira BioSciences?
- What is Pacira BioSciences annual short term debt year-on-year change?
- What is Pacira BioSciences quarterly short term debt?
- What is the all time high quarterly short term debt for Pacira BioSciences?
- What is Pacira BioSciences quarterly short term debt year-on-year change?
What is Pacira BioSciences annual short term debt?
The current annual short term debt of PCRX is $210.66 M
What is the all time high annual short term debt for Pacira BioSciences?
Pacira BioSciences all-time high annual short term debt is $382.59 M
What is Pacira BioSciences annual short term debt year-on-year change?
Over the past year, PCRX annual short term debt has changed by +$193.22 M (+1107.79%)
What is Pacira BioSciences quarterly short term debt?
The current quarterly short term debt of PCRX is $210.66 M
What is the all time high quarterly short term debt for Pacira BioSciences?
Pacira BioSciences all-time high quarterly short term debt is $382.59 M
What is Pacira BioSciences quarterly short term debt year-on-year change?
Over the past year, PCRX quarterly short term debt has changed by $0.00 (0.00%)